Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma

Jonathan Geoffrey Ayres, B. Higgins, E. R. Chilvers, G. Ayre, M. Blogg, Helen Catherine Fox

    Research output: Contribution to journalArticlepeer-review

    258 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma'. Together they form a unique fingerprint.

    Medicine & Life Sciences